Our data suggest that the tumor suppression efficacy of IFNα-AF-MSCs is attributed to angiogenesis reduction, as well as the induction of apoptosis and inhibition of cell proliferation in tumor cells mediated by these IFNα-overexpressing stem cells. The gene discussed is IFNA17; the disease is neoplasm.